Lifevantage Corporation
LFVN
Market Cap$154.46M
Close$
$14.34
16.9% upside
Current Fair Value
16.9% upsideUndervalued by 16.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $154.46 Million |
|---|---|
| Enterprise Value | $146.29 Million |
| Dividend Yield | $0.16 (1.3039934800326%) |
| Earnings per Share | $0.24 |
| Beta | 0.44 |
| Outstanding Shares | 12,211,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 20.41 |
|---|---|
| PEG | 10.73 |
| Price to Sales | 0.77 |
| Price to Book Ratio | 6.14 |
| Enterprise Value to Revenue | 0.75 |
| Enterprise Value to EBIT | 16.39 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Lifevantage Corporation
CEO: Darren Jensen LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary suppl...